Lise Tarnow Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

11/2017	Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
10/2015	Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.
8/2015	IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
6/2015	ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes.
1/2015	Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.
6/2014	Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.
12/2013	CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
9/2012	New susceptibility loci associated with kidney disease in type 1 diabetes.
5/2011	A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
2/2011	Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lise Tarnow Research Topics

Disease

60	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 11/2003
53	Diabetic Nephropathies (Diabetic Nephropathy) 11/2017 - 07/2002
40	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2004
17	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2013
17	Albuminuria 01/2021 - 07/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2004
12	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 11/2003
8	Inflammation (Inflammations) 11/2011 - 05/2005
6	Insulin Resistance 07/2021 - 03/2004
6	Heart Failure 11/2020 - 05/2014
5	Diabetes Complications 01/2022 - 03/2011
5	Weight Gain 01/2017 - 11/2009
5	Hypertension (High Blood Pressure) 12/2014 - 04/2005
4	Stroke (Strokes) 01/2021 - 01/2005
4	Overweight 01/2019 - 04/2015
3	Wounds and Injuries (Trauma) 11/2018 - 11/2011
3	Body Weight (Weight, Body) 04/2015 - 01/2008
3	Hyperkalemia 12/2014 - 12/2005
2	Obstructive Sleep Apnea 07/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 01/2005
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 11/2016
2	Weight Loss (Weight Reduction) 01/2019 - 03/2016
2	Chronic Renal Insufficiency 11/2010 - 07/2008
2	Proteinuria 02/2010 - 03/2004
1	Gestational Weight Gain 01/2021
1	Infections 10/2017
1	Ulcer 10/2017

Drug/Important Bio-Agent (IBA)

28	Insulin (Novolin)FDA Link 01/2022 - 01/2008
21	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2008
16	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2005
13	AlbuminsIBA 12/2014 - 04/2003
10	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2008
10	Liraglutide FDA Link 11/2020 - 05/2014
9	CreatinineIBA 12/2014 - 08/2002
8	Antihypertensive Agents (Antihypertensives)IBA 10/2013 - 02/2003
6	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020 - 05/2014
6	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015 - 01/2013
6	Losartan (Cozaar)FDA LinkGeneric 04/2009 - 07/2002
5	CholesterolIBA 01/2021 - 08/2002
5	Angiotensin Receptor AntagonistsIBA 12/2015 - 07/2002
5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 10/2015 - 06/2004
5	Connective Tissue Growth FactorIBA 01/2015 - 06/2005
5	AdiponectinIBA 11/2013 - 11/2006
4	pro-brain natriuretic peptide (1-76)IBA 11/2017 - 11/2007
4	C-Reactive ProteinIBA 11/2017 - 10/2006
4	Insulin Detemir (Levemir)FDA Link 10/2016 - 11/2011
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2015 - 11/2003
4	Irbesartan FDA LinkGeneric 05/2012 - 03/2004
4	repaglinide (Prandin)FDA Link 03/2011 - 01/2008
4	Advanced Glycation End ProductsIBA 02/2011 - 12/2006
3	Insulin Glargine (Lantus)FDA Link 01/2022 - 07/2019
3	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2022 - 06/2012
3	insulin degludecIBA 01/2022 - 07/2019
3	Biphasic InsulinsIBA 01/2022 - 11/2009
3	Glucagon-Like Peptide-1 ReceptorIBA 11/2020 - 04/2015
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 07/2013
3	Peptides (Polypeptides)IBA 11/2016 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 08/2015 - 02/2010
3	ProteomeIBA 12/2010 - 07/2008
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2009 - 05/2003
3	Edetic Acid (EDTA)FDA Link 04/2008 - 09/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008 - 01/2005
2	Indicators and Reagents (Reagents)IBA 11/2018 - 10/2017
2	OsteoprotegerinIBA 11/2016 - 12/2010
2	Insulin Aspart (NovoLog)FDA Link 10/2016 - 02/2016
2	AntigensIBA 02/2016 - 05/2008
2	LipidsIBA 01/2016 - 01/2008
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2015 - 06/2005
2	Vitamin D FDA LinkGeneric 06/2015 - 10/2010
2	Spironolactone (Aldactone)FDA LinkGeneric 10/2013 - 12/2005
2	Type 1 Angiotensin ReceptorIBA 05/2011 - 11/2003
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2010 - 11/2007
2	SecretagoguesIBA 11/2009 - 01/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2009 - 09/2005
2	UDP Xylose-Protein XylosyltransferaseIBA 12/2008 - 10/2006
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 04/2008 - 03/2004
2	EnzymesIBA 04/2007 - 06/2005
2	Angiotensin IIIBA 05/2003 - 02/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Natriuretic PeptidesIBA 11/2020
1	AdrenomedullinIBA 11/2020
1	SodiumIBA 11/2020
1	NAD (NADH)IBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2019
1	FibrinIBA 11/2018
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Troponin T (Troponin T1)IBA 11/2017
1	ProfilIBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2017

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2004
5	Glycemic Control 01/2022 - 10/2004
4	Continuous Positive Airway Pressure 07/2021 - 03/2013
4	Surgical Amputation (Amputations) 10/2018 - 01/2005
2	Kidney Transplantation 01/2021 - 09/2012
2	Subcutaneous Injections 03/2016 - 11/2011
1	Fitness Trackers 01/2021
1	Injections 01/2021